Humanity & Health Medical Group Limited
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.hnhmgl.com/en/
Liver Injury After COVID-19 Vaccination
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 5000
- Registration Number
- NCT05470894
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Medical Group Limited, Hong Kong, Hong Kong
🇯🇵Nihon University School of Medicine, Tokyo, Japan
🇯🇵Tokyo University, Tokyo, Japan
A Study to Evaluate Vaccines Against COVID-19 in the Real World
Withdrawn
- Conditions
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2022-08-03
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Registration Number
- NCT04775056
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Medical Group, Hong Kong, Hong Kong
Antibody Response to COVID-19 Vaccines in Liver Disease Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2023-10-04
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 232
- Registration Number
- NCT04775069
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Medical Group Limited, Hong Kong, Hong Kong
Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 17
- Registration Number
- NCT04428437
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Clinical Trial Centre, Hong Kong, Hong Kong SAR, Hong Kong
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-04-02
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 30
- Registration Number
- NCT03899428
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Research Centre, Hong Kong, Hong Kong SAR, Hong Kong
Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 53
- Registration Number
- NCT03830749
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Research Centre, Hong Kong, Hong Kong SAR, Hong Kong
Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Registration Number
- NCT03794258
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Research Centre, Hong Kong, Hong Kong SAR, Hong Kong
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 2000
- Registration Number
- NCT03792919
- Locations
- ðŸ‡ðŸ‡°
Humanity & Health Research Centre, Hong Kong, Hong Kong SAR, Hong Kong
The Overall Survival of Patients With Unresectable HCC in Real-life
Recruiting
- Conditions
- First Posted Date
- 2018-08-02
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Humanity & Health Medical Group Limited
- Target Recruit Count
- 5000
- Registration Number
- NCT03612726
- Locations
- 🇯🇵
Tokyo University, Tokyo, Japan
🇨🇳Beijing 302 Hospital, Beijing, China
ðŸ‡ðŸ‡°Humanity & Health Medical Group Limited, Hong Kong, Hong Kong
© Copyright 2024. All Rights Reserved by MedPath